All In Biotech

Company · REGN

Regeneron

Includes drugs filed under related and acquired sponsor names. Trials are searched under: Regeneron Pharmaceuticals.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

9

9 still marketed

Novel approvals

8

Approvals since 2021

34

Originals and new uses

Phase 3 trials

105

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

  • Pasatru approved NovelPriority reviewOrphanAug 19, 2026
  • Dupixent new use Apr 22, 2026
  • Eylea Hd new use Apr 2, 2026
  • Dupixent new use Priority reviewFeb 23, 2026
  • Eylea Hd new use Priority reviewNov 19, 2025
  • Libtayo new use Priority reviewOct 29, 2025
  • Praluent new use OrphanOct 9, 2025
  • Libtayo new use Priority reviewOct 8, 2025
  • Evkeeza new use Breakthrough therapyPriority reviewOrphanSep 25, 2025
  • Dupixent new use Priority reviewOrphanJun 18, 2025

Drugs in development (41)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • REGN7508CenvacibartPhase 312 trials

    Regeneron · Atrial Fibrillation (AF), Venous Thromboembolism (VTE), Venous Thromboembolism

  • FianlimabREGN3767Phase 311 trials

    Regeneron · Melanoma, Non-small Cell Lung Cancer, Hepatocellular Carcinoma

  • OlatorepatideHS-20094Phase 38 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight or Obesity, Overweight or Obesity Without Diabetes

  • OdronextamabREGN1979, OrdsponoPhase 37 trials

    Regeneron · Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), Relapsed/Refractory Follicular Lymphoma

  • CemdisiranALN-CC5Phase 35 trials

    Regeneron · Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis, Age-related Macular Degeneration (AMD)

  • MibavademabREGN4461Phase 35 trials

    Regeneron · Generalized Lipodystrophy, Functional Hypothalamic Amenorrhea, FHA

  • REGN9933amrecibartPhase 35 trials

    Regeneron · Atrial Fibrillation (AF), Peripheral Artery Disease (PAD), Venous Thromboembolism (VTE)

  • ALN-CIDEBPhase 34 trials

    Regeneron · Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, MASLD

  • CMP 001VidutolimodPhase 32 trials

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • REGN1908FreneslerbartPhase 32 trials

    Regeneron · Allergic Conjunctivitis

  • REGN1909MevonlerbartPhase 32 trials

    Regeneron · Allergic Conjunctivitis

  • REGN5713BremzalerbartPhase 31 trial

    Regeneron · Allergic Conjunctivitis

  • REGN5715AtisnolerbartPhase 31 trial

    Regeneron · Allergic Conjunctivitis

  • UbamatamabREGN4018Phase 24 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN10597PD-1-IL2Ra-IL2 immunotherapyPhase 23 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN5678NezastomigPhase 23 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN7075marlotamigPhase 23 trials

    Regeneron · Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer

  • ALN-PNPPhase 22 trials

    Regeneron · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Healthy Volunteers

  • Fianlimab [Fixed ]Phase 22 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN4336Phase 22 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN5459Vonsetamig, BCMAxCD3Phase 22 trials

    Regeneron · Chronic Kidney Disease (CKD), Relapsed Multiple Myeloma, Refractory Multiple Myeloma

  • REGN7544baloncibartPhase 22 trials

    Regeneron · Postural Orthostatic Tachycardia Syndrome (POTS), Sepsis-Induced Hypotension

  • ALN-6457ALN-PRNPPhase 21 trial

    Regeneron · Prion Disease

  • BNT116Phase 21 trial

    Regeneron · Advanced Non-Small Cell Lung Cancer

  • FDC fianlimabPhase 21 trial

    Regeneron · Head and Neck Squamous Cell Carcinoma (HNSCC)

Recruiting Phase 3 trials

Largest first.

Marketed drugs (9)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.